Stryker Corporation $SYK Shares Bought by Sectoral Asset Management Inc.

Sectoral Asset Management Inc. grew its holdings in shares of Stryker Corporation (NYSE:SYK) by 52.3% during the 4th quarter, HoldingsChannel.com reports. The firm owned 6,550 shares of the medical technology company’s stock after buying an additional 2,250 shares during the period. Stryker makes up approximately 1.8% of Sectoral Asset Management Inc.’s investment portfolio, making the stock its 17th largest holding. Sectoral Asset Management Inc.’s holdings in Stryker were worth $2,302,000 at the end of the most recent quarter.

Other institutional investors have also modified their holdings of the company. Czech National Bank boosted its stake in shares of Stryker by 3.9% during the 4th quarter. Czech National Bank now owns 90,755 shares of the medical technology company’s stock worth $31,898,000 after acquiring an additional 3,366 shares in the last quarter. Davis R M Inc. boosted its stake in shares of Stryker by 1.8% during the 3rd quarter. Davis R M Inc. now owns 138,732 shares of the medical technology company’s stock worth $51,285,000 after acquiring an additional 2,512 shares in the last quarter. Terra Alpha Investments LLC acquired a new position in shares of Stryker during the 3rd quarter worth approximately $1,216,000. Kepler Cheuvreux Suisse SA acquired a new position in shares of Stryker during the 3rd quarter worth approximately $27,952,000. Finally, Daymark Wealth Partners LLC raised its position in shares of Stryker by 436.0% during the 4th quarter. Daymark Wealth Partners LLC now owns 45,863 shares of the medical technology company’s stock worth $16,119,000 after purchasing an additional 37,307 shares during the last quarter. Hedge funds and other institutional investors own 77.09% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts recently issued reports on the company. Evercore set a $355.00 price objective on Stryker in a research report on Friday, May 1st. Wall Street Zen downgraded Stryker from a “buy” rating to a “hold” rating in a research report on Saturday, May 16th. Leerink Partners initiated coverage on Stryker in a research report on Monday, April 13th. They set an “outperform” rating and a $410.00 price objective for the company. Wells Fargo & Company cut their price target on Stryker from $456.00 to $418.00 and set an “overweight” rating for the company in a report on Friday, May 1st. Finally, Robert W. Baird set a $385.00 price target on Stryker in a report on Friday, May 1st. Sixteen investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $395.48.

Stryker Trading Down 0.0%

Shares of SYK opened at $316.39 on Monday. The stock has a fifty day moving average of $325.22 and a two-hundred day moving average of $349.76. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.25 and a current ratio of 2.11. The company has a market capitalization of $121.29 billion, a PE ratio of 36.62, a price-to-earnings-growth ratio of 1.99 and a beta of 0.80. Stryker Corporation has a fifty-two week low of $281.00 and a fifty-two week high of $404.87.

Stryker (NYSE:SYK) last issued its quarterly earnings results on Thursday, April 30th. The medical technology company reported $2.60 earnings per share for the quarter, missing the consensus estimate of $2.98 by ($0.38). The business had revenue of $6.02 billion during the quarter, compared to analyst estimates of $6.34 billion. Stryker had a net margin of 13.20% and a return on equity of 23.42%. The company’s revenue was up 2.6% on a year-over-year basis. During the same quarter last year, the firm posted $2.84 earnings per share. Stryker has set its FY 2026 guidance at 14.900-15.100 EPS. As a group, analysts forecast that Stryker Corporation will post 14.98 EPS for the current year.

Stryker Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Tuesday, June 30th will be issued a dividend of $0.88 per share. This represents a $3.52 dividend on an annualized basis and a dividend yield of 1.1%. The ex-dividend date is Tuesday, June 30th. Stryker’s dividend payout ratio is presently 40.74%.

Insider Activity at Stryker

In other news, VP M Kathryn Fink sold 3,500 shares of the company’s stock in a transaction on Monday, May 11th. The stock was sold at an average price of $283.45, for a total transaction of $992,075.00. Following the completion of the sale, the vice president directly owned 177 shares in the company, valued at $50,170.65. This represents a 95.19% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link. 4.60% of the stock is currently owned by insiders.

About Stryker

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.